Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.

The Israel Medical Association journal : IMAJ

Volumn 4, Issue 11, 2002, Pages 1003-1005

  Harenberg, Job ^a   Ingrid, Jörg ^a   Tivadar, Fenyvesi ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZETIDINE DERIVATIVE; BENZYLAMINE DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; XIMELAGATRAN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HUMAN; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; AZETIDINES; BENZYLAMINES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; VENOUS THROMBOSIS; WARFARIN;

EID: 0036832646     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)